Efavirenz, emtricitabine, and tenofovir and Ibritumomab Intravenous
Determining the interaction of Efavirenz, emtricitabine, and tenofovir and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: efavirenz / emtricitabine / tenofovir
Brand name: Atripla
Synonyms: Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Efavirenz, emtricitabine, and tenofovir-Ibritumomab Tiuxetan
- Efavirenz, emtricitabine, and tenofovir-Ibrutinib
- Efavirenz, emtricitabine, and tenofovir-Ibrutinib Capsules
- Efavirenz, emtricitabine, and tenofovir-Ibrutinib Tablets
- Efavirenz, emtricitabine, and tenofovir-Ibu
- Efavirenz, emtricitabine, and tenofovir-IBU Tablets
- Ibritumomab Intravenous-Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate
- Ibritumomab Intravenous-Efavirenz, lamivudine, and tenofovir
- Ibritumomab Intravenous-Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate
- Ibritumomab Intravenous-Effaclor Duo
- Ibritumomab Intravenous-Effer-K
- Ibritumomab Intravenous-Effer-K Tablets